---
title: "AngioDynamics announces CE mark approval in Europe for the Auryon system"
date: "2024-09-03T16:03:36.000Z"
publishedDate: "3 septembre 2024"
summary: "AngioDynamics today announced European CE mark approval of the Auryon atherectomy system, designed for the treatment of peripheral arterial disease (PAD), including chronic limb-threatening ischaemia (CLTI) and in-stent restenosis (ISR). The Auryon atherectomy system uses solid-state laser technology to treat PAD lesions and occlusions."
importance: ""
sourceUrl: "https://vascularnews.com/angiodynamics-announces-ce-mark-approval-in-europe-for-the-auryon-system/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2024-09-03-angiodynamics-announces-ce-mark-approval-in-europe-for-the-auryon-system"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2020/01/AngioDynamics-logo-766x512-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/angiodynamics-announces-ce-mark-approval-in-europe-for-the-auryon-system/"
---

![AngioDynamics announces CE mark approval in Europe for the Auryon system](https://vascularnews.com/wp-content/uploads/sites/7/2020/01/AngioDynamics-logo-766x512-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/angiodynamics-announces-ce-mark-approval-in-europe-for-the-auryon-system/*

## L’essentiel

AngioDynamics today announced European CE mark approval of the Auryon atherectomy system, designed for the treatment of peripheral arterial disease (PAD), including chronic limb-threatening ischaemia (CLTI) and in-stent restenosis (ISR). The Auryon atherectomy system uses solid-state laser technology to treat PAD lesions and occlusions.

## Lien source

https://vascularnews.com/angiodynamics-announces-ce-mark-approval-in-europe-for-the-auryon-system/
